2021 Annual Meeting | Neuro-oncology Around the World—Global Perspective on Brain Cancer Patient Care

Date Monday 04/19/21

Time 03:00 PM - 03:45 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (HeadTalks)

Director(s) Maciej M. Mrugala, MD, PhD, MPH, FAAN, , Alejandro Zavala Reina, ,

Topic(s) General Neurology, Neuro-oncology

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Other

Event Timeline
03:00 PM - 03:45 PM EDT	Speaker	Neuro-oncology Around the World—Global Perspective on Brain Cancer Patient Care Maciej M. Mrugala, MD, PhD, MPH, FAAN, , , Alejandro Zavala Reina,

Faculty Disclosures
	No disclosure on file
Alejandro Zavala Reina	No disclosure on file
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.

��ɫ����